drugset / Trial / NCT06755801
Nebivolol ANOCA Treatment Randomized Trial
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the effectiveness of the beta-blocker nebivolol in controlling symptoms and improving the quality of life in patients with angina and coronary microvascular dysfunction.
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-03-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nebivolol | Other / unclassified | 20 mg | — |